Type to search

Diseases Drug Development News

NHS To Roll Out Life-Extending Drug For Advanced Gastroesophageal Cancer

Share
NHS To Roll Out Life-Extending Drug For Advanced Gastroesophageal Cancer | PTF

NHS comments on NICE decision to approve Nivolumab to treat rare forms of gastroesophageal cancer after final draft guidance was published today (24 November 2022).

NHS National Cancer Director Professor Peter Johnson said: “Cancer of the oesophagus is one of the most difficult to diagnose and treat and this new life-extending drug, used with chemotherapy, will give hope to thousands of people with this illness, allowing them to spend more time with loved ones, enjoy a better quality of life and in some cases help them become cancer-free.

“It is yet another example of the NHS using its commercial capabilities to deliver cutting-edge drugs, combined with our work to catch cancers earlier than ever before, straight to patients who need them – giving them the best chance of surviving cancer.”

Tags:

People in this post:

Companies in this post:

Next Up